Position
Chief Commercial Officer
Company
Santhera Pharmaceuticals
PrattelnBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaPharmaceutical ManufacturingpharmaceuticalsDescription
Santhera Pharmaceuticals has announced the appointment of Marc Clausse as Chief Commercial Officer, effective June 1, 2026. He succeeds Geert Jan van Daal, who will retire after 11 years with the company.
Quick answer
Santhera Pharmaceuticals Appoints Marc Clausse as Chief Commercial Officer (March 10, 2026). Santhera Pharmaceuticals is based in Pratteln, Basel-Landschaft, Switzerland.
- Who is the new Chief Commercial Officer at Santhera Pharmaceuticals?
- Santhera Pharmaceuticals named Marc Clausse Chief Commercial Officer, announced March 10, 2026.
- What did Santhera Pharmaceuticals announce on March 10, 2026?
- Santhera Pharmaceuticals has announced the appointment of Marc Clausse as Chief Commercial Officer, effective June 1, 2026. He succeeds Geert Jan van Daal, who will retire after 11 years with the company.
- What does Santhera Pharmaceuticals do?
- Santhera Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative medicines for the treatment of rare neuromuscular and pulmonary diseases.
- Where is Santhera Pharmaceuticals based?
- Santhera Pharmaceuticals is based in Pratteln, Basel-Landschaft, Switzerland.
- Which similar companies made leadership changes around the same time?
- Minerva Neurosciences (April 2, 2026), MBX Biosciences, Inc. (March 10, 2026), Royalty Pharma plc (March 3, 2026) and Atossa Therapeutics (March 19, 2026) also announced leadership changes within 45 days of Santhera Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Minerva Neurosciences Appoints Dr. Sheila O’Connor as President and CEO (April 2, 2026)
- MBX Biosciences Appoints Karen Basbaum as Chief Business Officer (March 10, 2026)
- Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia (March 3, 2026)
- Atossa Therapeutics Appoints Kathy Puyana Theall and Adebola Giwa as Medical Directors (March 19, 2026)
- Aquestive Therapeutics Announces Departure of Chief Legal Officer (March 20, 2026)
- Aurinia Pharmaceuticals Appoints Kevin Tang as Chief Executive Officer and Ryan Cole as Chief Operating Officer (March 23, 2026)
Who to call at Santhera Pharmaceuticals, and when
A new leader at Santhera Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Santhera Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Santhera Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Santhera Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Santhera Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Santhera Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.